Table 2.
Analysis variables |
Pregnancy after MS diagnosis |
p-value | ||
---|---|---|---|---|
Yes (n = 82) | No (n = 346) | |||
Motherhood before MS diagnosis, n (%) | 28 (34.1%) | 152 (43.9%) | 0.11 | |
Maternity desire after MS diagnosis, n (%) | Unchanged | 65 (79.3%) | 173 (50%) | <0.01 |
Uncertain | 5 (6.1%) | 70 (20.2%) | ||
Changed | 12 (14.6%) | 103 (29.8%) | ||
Frequency of neurologist addressing family planning, n (%) | Never | 22 (26.8%) | 161 (46.5%) | 0.01 |
Occasionally | 15 (18.3%) | 56 (16.2%) | ||
Only at the patient’s request | 39 (47.6%) | 108 (31.2%) | ||
On every consultation | 6 (7.3%) | 21 (6.1%) | ||
Neurologist explained about risks related to DMTs and pregnancy, n (%) | Yes | 54 (65.9%) | 146 (42.2%) | <0.01 |
No | 28 (34.1%) | 200 (57.8%) | ||
Most common information source on MS treatments and pregnancy, n (%)a | Uncertain, none or informal | 19 (23.2%) | 168 (48.6%) | <0.01 |
Formal | 63 (76.8%) | 178 (51.4%) |
aInformal: relatives or friends, internet, other MS patients. Formal: physicians or patients’ organizations. DMTs: Drugs modified treatment.Bold numbers mark the degree of significance.